Imunon, Inc. (IMNN)

Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $12.27 million. The enterprise value is $11.42 million.

Market Cap	12.27M
Enterprise Value	11.42M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Imunon has 21.30 million shares outstanding. The number of shares has increased by 37.24% in one year.

Current Share Class	21.30M
Shares Outstanding	21.30M
Shares Change (YoY)	+37.24%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	1.31%
Owned by Institutions (%)	5.28%
Float	18.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	20.17
P/TBV Ratio	29.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 2.23.

Current Ratio	0.88
Quick Ratio	0.50
Debt / Equity	2.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -397.54% and return on invested capital (ROIC) is -199.09%.

Return on Equity (ROE)	-397.54%
Return on Assets (ROA)	-107.77%
Return on Invested Capital (ROIC)	-199.09%
Return on Capital Employed (ROCE)	-1,714.83%
Revenue Per Employee	n/a
Profits Per Employee	-$711,728
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.69% in the last 52 weeks. The beta is 1.93, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	1.93
52-Week Price Change	-58.69%
50-Day Moving Average	1.01
200-Day Moving Average	0.92
Relative Strength Index (RSI)	39.37
Average Volume (20 Days)	3,886,904

Short Selling Information

The latest short interest is 1.09 million, so 5.12% of the outstanding shares have been sold short.

Short Interest	1.09M
Short Previous Month	3.96M
Short % of Shares Out	5.12%
Short % of Float	5.84%
Short Ratio (days to cover)	0.21

Income Statement

Revenue	n/a
Gross Profit	1.13M
Operating Income	-18.27M
Pretax Income	-20.13M
Net Income	-17.79M
EBITDA	-18.03M
EBIT	-18.27M
Earnings Per Share (EPS)	-$1.39

Balance Sheet

The company has $2.87 million in cash and $1.01 million in debt, giving a net cash position of $1.86 million or $0.09 per share.

Cash & Cash Equivalents	2.87M
Total Debt	1.01M
Net Cash	1.86M
Net Cash Per Share	$0.09
Equity (Book Value)	452,028
Book Value Per Share	0.03
Working Capital	-704,931

Cash Flow

In the last 12 months, operating cash flow was -$15.83 million and capital expenditures -$277,438, giving a free cash flow of -$16.11 million.

Operating Cash Flow	-15.83M
Capital Expenditures	-277,438
Free Cash Flow	-16.11M
FCF Per Share	-$0.76

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.24%
Shareholder Yield	-37.24%
Earnings Yield	-133.94%
FCF Yield	-121.23%

Analyst Forecast

The average price target for Imunon is $14.00, which is 2,329.71% higher than the current price. The consensus rating is "Buy".

Price Target	$14.00
Price Target Difference	2,329.71%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1